journavx pain management - Search News

FDA approves new pain medicine

U.S. News & World Report · 1d

What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

Hosted on MSN · 1d

FDA approves new pain medicine as opioid alternative. What to know about Journavx

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

OurQuadCities · 7h

New non-opioid pain medication approved by FDA

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.

BioPharma Dive1d

A new, non-opioid pain drug is here. Getting it to patients could be agony.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

1d

FDA approves opiate-alternative acute pain management drug, local experts share their thoughts

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

Psychology Today1d

Treating Pain—Avoiding the Brain

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results